BioStorage Technologies Appoints Board of Directors.Business Editors/Health/Medical Writers INDIANAPOLIS--(BUSINESS WIRE)--Sept. 16, 2003 BioStorage Technologies, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control announced today it has completed the appointment of its board of directors. The board includes well-known figures in the Indianapolis area as well as people who are well-known in the life sciences industry. "This is an exciting milestone for BioStorage Technologies," said Dr. F. John Mills, chairman of the board and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the company. "It shows our continued progress in firmly establishing our new company. A strong board is critical to ensure good corporate governance Corporate Governance The relationship between all the stakeholders in a company. This includes the shareholders, directors, and management of a company, as defined by the corporate charter, bylaws, formal policy, and rule of law. and strategic direction. We are honored to have such an experienced group of individuals join us from the outset." The directors are: Dr. F. John MILLS - Chairman of the Board Dr. Mills is CEO of BioStorage Technologies. Previously he was corporate senior vice president and president of clinical support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services from 1998 to December 2001 for Covance, Inc. (NYSE NYSE See: New York Stock Exchange :CVD CVD Cardiovascular disease, see there ), a leading contract research organization headquartered in Princeton, N.J. Mills was responsible for a global division employing 2,500 people operating a $300 million annual budget. Oscar MORALEZ - Board Member Mr. Moralez is president and founder of BioStorage Technologies. Most recently, he was director of specialty services at Covance Central Laboratories. He was responsible for a specimen management department that handled and stored approximately two million clinical trials specimens. Mike ALLEY - Board Member Mr. Alley owns Patriot Investments, LLC, of Indianapolis, through which he conducts an array of business consulting and investment activities. He also owns Electronic Evolutions Inc., Central Indiana's leading provider of custom consumer electronics, media, and control devices for homes and businesses. Alley retired in 2002 as president and CEO of Fifth Third Bank, Central Indiana, an affiliate of Fifth Third Bancorp (NYSE:FITB FITB Fill In The Blank FITB Future Income Tax Benefit FITB Fédération Internationale de Tchoukball (International Tchoukball Federation) ), after leading the growth of Fifth Third to more than $4.8 billion in Indiana assets and status as the largest state-chartered bank in Indiana. Ron HENRIKSEN - Board Member Mr. Henriksen is chief investment officer of Twilight Venture Partners, a life science venture capital company based in Indianapolis. Previously, he was president of Indiana University's Advanced Research and Technology Institute; CEO of Itasca Ventures, a Minneapolis life sciences incubator; and president of Khepri Pharmaceuticals, a San Francisco biotechnology company. He also worked 23 years at Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. (NYSE:LLY) in a variety of management positions. He was responsible for Lilly biotechnology business development from 1983 to 1993. Robert C. RANDOLPH - Board Member Mr. Randolph is a partner in the Ellicot City, Md., law firm of Carr, Falkner & Swanson. He advises clients on international mediation and international tax. From 1997 to 2001, he was responsible for the U.S. Agency for International Development (USAID USAID United States Agency for International Development USAID Agencia de los Estados Unidos para el Desarrollo Internacional (Spanish) ) activities in Asia and the Middle East. He was closely involved in President Clinton's Middle East peace initiative as well as in rebuilding Asian economies after the 1997 Asian financial crisis. Prior to 1997, he was international trade representative for the State of Washington and served earlier as CEO of Chloride Eastern in Singapore, 1988 - 1991. David T. WONG, Ph.D. - Board Member Dr. Wong, president of DT Wong Consulting, LLC, of Indianapolis, is an internationally acknowledged biochemist and neuropharmacologist. He worked from 1968 with Lilly Research Laboratories Lilly Research Laboratories is the organizational name of the global pharmaceutical research and development organization of Eli Lilly and Company, one of the world's largest pharmaceutical corporations. until his retirement as a Lilly Research Fellow in 2000. He is a co-discoverer and co-inventor of several drugs that revolutionized psychiatry and neuropharmacology neuropharmacology /neu·ro·phar·ma·col·o·gy/ (-fahr?mah-kol´ah-je) the scientific study of the effects of drugs on the nervous system. neu·ro·phar·ma·col·o·gy n. including Prozac, Strattera and Cymbalta. Wong has received several notable awards for his contributions to science. About the company, BioStorage Technologies BioStorage Technologies is an Indiana Limited Liability Company located in Indianapolis. BioStorage Technologies provides management, logistics and storage services for biological specimens and related data for companies and other organizations in the life sciences industry. The company's website is www.bst-indy.com. Business operations are planned to commence this fall. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion